Work

Gene expression and cytokine modulation in a first in human (FIH) study of a pan BET inhibitor ABBV-075 in solid tumors.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.2570

Authors: Bert H. O'Neil, Dimple Modi, Patricia LoRusso, Shekman Wong, Monica Motwani, Jasgit C. Sachdev, Johannes E. Wolff, Sapna Pradyuman Patel, Beibei Hu, Russell Zelig Szmulewitz, Anjla Sood, Minal A. Barve, Mark D. McKee, Sarina Anne Piha-Paul

Institutions: Indiana University School of Medicine, AbbVie (United States), Yale Cancer Center, The University of Texas MD Anderson Cancer Center, University of Chicago, Texas Oncology

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891130469

Cites:

Cited by: 1

Related to: 10